A Patient with Severe Pulmonary Hypertension for Hip Arthroplasty
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Pulmonary arterial hypertension (PAH) is defined as a mean PA pressure ≥25 mmHg at rest or 30 mmHg with exercise without left ventricular failure (left ventricular end diastolic pressure (LVEDP) ≤15) . Most patients present with symptoms of progressive exertional dyspnea, which may also include angina and syncopal episodes. If these patients are not treated, the disease will progress to right heart failure, with peripheral edema, ascites, and hepatomegaly.
Pulmonary hypertension is a known risk factor for morbidity and mortality during noncardiac surgery . Stress, pain, acidosis, and hypoxemia which are often encountered during surgery may increase PAH and precipitate right ventricular decompensation. In addition during total hip arthroplasty, the embolization of bone marrow debris and fat to the lungs will further increase pulmonary arterial pressures and acute cor pulmonale . This is a case report of a young patient with severe pulmonary hypertension who died afte
- Apostolou CD, Skourtas CE, Tsifetakis SD, Papagelopoulos PJ. Fat embolism after uncemented total Hip arthroplasty. Clin Orthop Relat Res. 2002; 398: 153-156. CrossRef
- Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCoy DC, Simmoneau G. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004; 126: 35S-65S. CrossRef
- Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV. Medical therapy for pulmonary arterial hypertension updated ACCP evidence-based clinical practice guidelines. Chest. 2007; 131: 1917-1928. CrossRef
- Bapoje SR, Whitaker JF, Schulz T, Chu ES, Albert RK. Preoperative evaluation of the patient with pulmonary disease. Chest 2007;132.
- Braun EB, Palin CA, Hogue CW. Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol. Anesth Analg. 2004; 99: 36-37. CrossRef
- Ereth MH, Weber JG, Abel HD, et al. Cemented versus Non-cemented total Hip arthroplasty-embolism, hemodynamics, and intrapulmonary shunting. Mayo Clin Proc. 1992; 67(11): 1066-1074. CrossRef
- Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Eng J Med. 2004; 351: 1655-1665. CrossRef
- Fox C, Kalarickal PL, Yarborough MJ, Jin JY. Perioperative management including new pharmacological vistas for patients with pulmonary hypertension for noncardiac surgery. Curr Opin Anesth. 2008; 21: 467-472. CrossRef
- Lai HC, Lai HC, Wong KY, Lee WL, Ting CT, Liu TJ. Severe pulmonary hypertension complicates postoperative outcome of cardiac surgery. Br J Anaesth. 2007; 126: 1-7.
- MacKnight B, Martinez EA, Simon BA. Anesthetic management of patients with pulmonary hypertension. Sem Cardiothoracici Vasc Anesthesia. 2008; 12: 91-96. CrossRef
- Nathan SD, Oksana AS, Shahzad A, Urbanek S, Barnett SD. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007;131.
- Opitz CF, Wensel R, Winkler J. Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. Eur Heart J. 2005; 174: 1257-1263.
- Ramakrishna G, Sprung J, Ravi BS. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol. 2005; 45: 1691-1699. CrossRef
- Rubin LJ, Badesch DB. Evaluation and management of the patient with pulmonary arterial hypertension. Am Intern Med. 2005; 143: 282-292. CrossRef
- A Patient with Severe Pulmonary Hypertension for Hip Arthroplasty
HSS Journal ®
Volume 10, Issue 2 , pp 171-179
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links